To help healthcare providers and insurers deliver optimal care beyond the medical practice with excellent teams empowered by scalable technology.
ChronWell was formed in 2017 by the team that built the largest Gastroenterology information technology platform in the US with the vision to change Workers Compensation by spending the right amount of time on the simple things that can help injured workers and patients take giant leaps forward.
The company eventually developed a unique and dynamic platform that tracked the progress of an injury from the initial point in which a worker was injured through return to work. This lead to a revolutionary Early Intervention program that has helped reduce costs, track injuries and assist in appropriate reporting. As the platform evolved, the team realized our solutions could be used on a larger scale to help
healthcare providers manage expensive chronic conditions beyond the medical practice, capitalizing on new care management opportunities approved by Medicare. Traditional practices did not have the team or information systems to manage patients remotely and they relied on our experience partnering with large medical practices to implement innovative programs to reach beyond the practice. The new COVID-19 Pandemic accelerated our development timeline and forced impaired practices to activate new revenue lines to manage patients remotely, leading to a different way to think about patient care. This story is still being written today
ChronWell is here to lead the way through the digital transformation of our healthcare system. We are focused on better outcomes, specific conditions, access to modern technologies, all with the ability to provide even more compassion in patient care. ChronWell’s forward-thinking approach features the ability to care for patients, drive at better outcomes, and increase practice revenue.
Based in Sunrise, Florida, ChronWell was founded in 2017 by Dr. Joe Rubinsztain, Salomon Sredni and Sam Rubinsztain. The purpose: To disrupt the healthcare and workers’ compensation system in America with an efficient, technology-driven approach to manage care and digital health.
ChronWell is an innovative company that helps healthcare specialty providers deliver excellent care to patients beyond the medical practice. With new technologies paired with remote care professionals, ChronWell' coordinated-care services engages patients with chronic conditions trough a series of proprietary capabilities and technology.
Joe Rubinsztain, MD
CEO and Co-Founder
Innovation is high on Joe’s priority list. By the time ChronWell launched in 2017, Joe—a seasoned entrepreneur and leader in Healthcare Information Technology—was already shaking things up. His trailblazing can-do attitude has always pushed him toward fulfilling unmet needs. He founded gMed in 1997, a firm that was recently sold to Modernizing Medicine. Joe continues on a path of active investment and plays a strategic role as a sought-after board member for businesses, NGOs, and very focused on disrupting the Digital Health space.
Sam Rubinsztain
President and Co-Founder
Sam is a respected and accomplished product leader in the Healthcare Information Technology field. Not only does his name accompany the launch and management of award-winning clinical and financial products, but he is also known as a co-founder of gMed, which was recently sold to Modernizing Medicine. Sam continues to play a strategic role as an active investor and board member in the Healthcare Information, Administrative and Insurance Technology space.
Nev Terzieva
EVP of Customer Success
Nev is an experienced sales executive and a sales leader. She brings to the team deep understanding of technology, healthcare, and the cross-section of the two. Her professional accomplishments also span areas of product development, product launch, and commercialization. She brings to the team deep understanding of sales management, healthcare, insurance, and technology.
Matt Schreiber
Chief Growth Officer
With 25 plus years in healthcare and workers’ compensation as a senior leader, Matt is Chronwell’s Chief Growth Officer. Joining the team in 2018, he is responsible for all commercial aspects of the organization with a specific focus on growth and customer success. Matt held senior management positions at Modernizing Medicine, gMed, myMatrixx (Express Scripts), PMSI (Optum), Cigna and Medco Health (Merck-Medco). Matt earned his MBA and a second master’s degree in technology from the New Jersey Institute of Technology. His undergraduate degree was completed at the University of Cincinnati where he earned a Bachelor of Science degree in Health Planning Administration.
Marina Simonian
VP of Product Management
Marina brings 14 years of experience in Healthcare IT and product management, spanning a multitude of roles in the definition, design, development and delivery of award winning products. She holds a Masters in Psychology from Yerevan State University in Armenia, and an MBA from Texas A&M University. Marina combines her passion for design-driven product innovation with life-long interest in behavioral economics and psychology.
Myron Falchuck, MD
Advisor
Dr. Myron Falchuk is the emeritus Chief of Clinical Gastroenterology for the Beth Israel Deaconess Medical Center (BIDMC), a world-class teaching hospital of Harvard Medical School. His experience spans the public, private, research and academic fields since 1967. Dr. Falchuk is currently an active corporate advisor, and mentor for Harvard GI fellows and faculty. He received his B.M.S. from Dartmouth Medical School, and his M.D. from Harvard Medical School. His role will be to help guide ChronWell in its current clinical programs and advance its future capabilities and services.
Stephen Harrison, M.D, FACP, FAASLD
Advisor
Dr. Harrison earned his medical degree from the University of Mississippi School of Medicine. He completed his internal medicine residency and gastroenterology fellowship at Brooke Army Medical Center and a 4th year advanced liver disease fellowship at Saint Louis University. He is board certified in both Internal Medicine and Gastroenterology. Dr. Harrison is currently a Visiting Professor of Hepatology at the Radcliffe Department of Medicine, University of Oxford. He is internationally known for studies in hepatitis C and non-alcoholic fatty liver disease with over 200 peer reviewed publications in these fields. Currently, Dr. Harrison currently serves as the Medical Director for Pinnacle Clinical Research and the President of Summit Clinical Research.
